Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Sales | 0 | 42 | 0 | 0 | 114 |
| Gross Profit | N/A | 40 | N/A | N/A | 110 |
| Operating Expenses | 1,881 | 1,740 | 2,239 | 2,277 | 1,980 |
| Operating Income | -1,881 | -1,698 | -2,239 | -2,277 | -1,866 |
| Other Income | 1 | 18 | -8 | 11 | -24 |
| Pre-tax Income | -1,880 | -1,680 | -2,247 | -2,266 | -1,890 |
| Net Income Continuous | -1,880 | -1,675 | -2,247 | -2,266 | -1,891 |
| Net Income | $-1,880 | $-1,675 | $-2,247 | $-2,266 | $-1,891 |
| EPS Basic Total Ops | -0.97 | -0.92 | -1.56 | -1.65 | -1.44 |
| EPS Basic Continuous Ops | -0.97 | -0.92 | -1.51 | -1.65 | -1.44 |
| EPS Diluted Total Ops | -0.97 | -0.92 | -1.56 | -1.65 | -1.44 |
| EPS Diluted Continuous Ops | -0.97 | -0.92 | -1.51 | -1.65 | -1.44 |
| EBITDA(a) | $-1,854 | $-1,664 | $-2,209 | $-2,251 | $-1,836 |